Literature DB >> 21063997

[Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].

Hatice Türk Dağı1, Mehmet Ozdemir, Mahmut Baykan, Bülent Baysal.   

Abstract

Human parvovirus B19 is a small, non-enveloped, icosahedral symmetric, single-stranded DNA virus that can cause a number of diseases, notably erythema infectiosum in children and aplastic crisis in patients with chronic hemolytic disorders. There have been limited data on the epidemiological pattern of parvovirus B19 infection in Turkey. The objective of this study was to investigate the seroprevalence of parvovirus B19 in Konya province (Central Anatolia), Turkey. Parvovirus B19 IgG antibodies were investigated by a commercial ELISA kit (RIDASCREEN, R-Biopharm AG, Germany) in 631 adults (age range: 18-> 60 years) and 542 children (age range: 0-17 years). The overall prevalence of parvovirus B19 IgG antibodies was 28.9%. The rate of parvovirus B19 IgG positivity was 20.7% (112/542) in the 0-17 years age group and was 36% (227/631) in the adult population. No significant difference in seropositivity rates were detected in terms of sex in children and adult group (p>0.05 in both groups). The rates of parvovirus B19 IgG seropositivity were 15.8% in 0-4 years age group, 16% in 5-9 years, 24.2% in 10-14 years, 40.9% in 15-19 years, 34.7% in 20-29 years, 35.5% in 30-39 years, 32.2% in 40-49 years, 37.5% in 50-59 years and 53.8% in > 60 years age group. The seropositivity rates in 0-4 and 5-9 years age groups were lower than the other age groups and the difference was statistically significant (p< 0.05). To determine the prevalence of parvovirus B19 in different age groups in different geographical areas is necessary since this will provide important information about the epidemiology of such infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063997

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  3 in total

1.  Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.

Authors:  O Mor; I Ofir; R Pavel; R Bassal; Z Kra-Oz; D Cohen; T Shohat; E Mendelson
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

2.  Parvovirus B19 in Croatia: A Large-Scale Seroprevalence Study.

Authors:  Tatjana Vilibic-Cavlek; Irena Tabain; Branko Kolaric; Klara Mihulja; Lana Blazevic; Maja Bogdanic; Dan Navolan; Natasa Beader; Anna Mrzljak
Journal:  Medicina (Kaunas)       Date:  2021-11-21       Impact factor: 2.430

3.  Coinfections identified from metagenomic analysis of cervical lymph nodes from tularemia patients.

Authors:  D N Birdsell; Y Özsürekci; A Rawat; A E Aycan; C L Mitchell; J W Sahl; A Johansson; R E Colman; J M Schupp; M Ceyhan; P S Keim; D M Wagner
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.